Markus Raderer
University of Vienna · 485 works · 18,531 citations · h-index 68
Top works
- Lanreotide in Metastatic Enteropancreatic Neuroendocrine Tumors
- Positron emission tomography with fluorine-18-2-fluoro-2-deoxy-D-glucose (F18-FDG) does not visualize extranodal B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT)-type
- T(14;18)(q32;q21) involving IGH andMALT1 is a frequent chromosomal aberration in MALT lymphoma
- Combined Irinotecan and Oxaliplatin Plus Granulocyte Colony-Stimulating Factor in Patients With Advanced Fluoropyrimidine/Leucovorin-Pretreated Colorectal Cancer
- Clinical trials of agents that reverse multidrug resistance. A literature review
- Phase II trial of two-weekly gemcitabine in patients with advanced biliary tract cancer
- Variable frequencies of MALT lymphoma-associated genetic aberrations in MALT lymphomas of different sites
- Inhibition of Metastases by Anticoagulants
- Randomized Multicenter Phase II Trial of Two Different Schedules of Capecitabine Plus Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer
- T(3;14)(p14.1;q32) involving IGH and FOXP1 is a novel recurrent chromosomal aberration in MALT lymphoma
- EGILS consensus report. Gastric extranodal marginal zone B-cell lymphoma of MALT
- Involvement of P-glycoprotein in the transmembrane transport of interleukin-2 (IL-2), IL-4, and interferon-gamma in normal human T lymphocytes
- ESMO Guidelines consensus conference on malignant lymphoma 2011 part 1: diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL)
- Irinotecan plus raltitrexed vs raltitrexed alone in patients with gemcitabine-pretreated advanced pancreatic adenocarcinoma
- Importance of extensive staging in patients with mucosa-associated lymphoid tissue (MALT)-type lymphoma
- The role of chemotherapy and radiation in the management of biliary cancer: a review of the literature
- Primary Follicular Lymphoma of the Duodenum Is a Distinct Mucosal/Submucosal Variant of Follicular Lymphoma: A Retrospective Study of 63 Cases
- Two Consecutive Phase II Studies of 5-Fluorouracil/Leucovorin/Mitomycin C and of Gemcitabine in Patients with Advanced Biliary Cancer
- Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- Fluorouracil plus racemic leucovorin versus fluorouracil combined with the pure l-isomer of leucovorin for the treatment of advanced colorectal cancer: a randomized phase III study.